TOGETHER WE CURE
2
At Akron Biotech, we manufacture ancillary
materials and provide specialized services to
accelerate the development and commercialization of
advanced therapies
33
INNOVATION AT AKRONSeveral patented and patent-pending technologies, including: non-DMSO preservation and cryopreservation solutions, recombinant protein formulations, engineered tissue products
COMMITMENT TO QUALITYISO 13485 compliant Quality Management System (QMS)
Products manufactured, tested, and released following cGMP guidelines
INDUSTRY PRESENCEBoard of ARM Foundation, CCRM, Standards Coordinating Body (SCB), ISCT Strategic Advisory Council
Work with FDA, ISO, NAS (Forum on Regenerative Medicine), SCB, and others to foster standardization
Industry Leadership
4
Recombinant Cytokines and Growth FactorsCryopreservation Media
Contract Development and Manufacturing Services
Proteins and Media Supplements
Our Capabilities
5CONFIDENTIAL NOT FOR FURTHER DISTRIBUTION
RECOMBINANT CYTOKINES AND GROWTH FACTORS
6
EXPERIENCE IN RECOMBINANT PROTEIN DEVELOPMENT DATES BACK TO 1989· Broad range of biosimilars registered from 1991 onward· Manufacturing IL-2 since 1996
PRODUCED UNDER CGMP FOR RESEARCH AND FURTHER MANUFACTURING USE:· Interleukins and beyond: IL-2 (lyophilized/liquid, 24-month stability), IL-7, IL-15, IL-21, EGF, EPO, SCF, and many more
SUPPORTING CLINICAL AND COMMERCIAL SUCCESS OF ADVANCED THERAPIES:· eCTD Drug Master File (DMF) for IL-2 (IL-7, IL-15 & IL-21 soon)· In-house sterile filtration (0.2 µm), lyophilization, and filling · Large scale (gram) production capacity to ensure security of supply· Purified through pharmaceutical processes (SEC/TFF)
cGMP Cytokines
7
Product Source Cat#rHu bFGF E. coli AK9784rHu EGF E. coli AK9797rHu EPO CHO AK9941rHu G-CSF E. coli AK8248rHu GM-CSF E. coli AK8341rHu PEG-GCSF E. coli AK9032rHu IFN alpha 2a E. coli AK8561rHu IFN alpha 2b E. coli AK8237rHu IGF-1 E. coli AK9901rHu IL-2 E. coli AK8223rHu IL-2 (pre-filled syringe) E. coli AK9984rHu IL-2 , 22 MIU AR1002rHu IL-3 Yeast AK9836rHu IL-4 Yeast AK9839rHu IL-6 E. coli AK9841rHu IL-7 E. coli AK9842rHu IL-12 Yeast AK9995rHu IL-15 E. coli AK9823 rHu IL-18 Yeast AK9999rHu IL-21 E. coli AK9833rHu Insulin Yeast AK9844rHu PDGF-BB Yeast AK8274rHu PDGF-AA Yeast AK9711rHu SCF Yeast AK9879rHu TGF beta 1 CHO AR1009rHu TNF alpha Yeast AK9887 rHu VEGF CHO AK9063
Growing Portfolio of cGMP Cytokines
8CONFIDENTIAL NOT FOR FURTHER DISTRIBUTION
CRYOPRESERVATION SOLUTIONS: DMSO AND DMSO-FREE
9
Ready-to-use solutions
DMSO-free
Serum-free
Animal component-free
Manufactured under ISO 13485 guidelines
Packaging options: vials, bottles, syringes & bags
CryoNovo DMSO-Free Cryopreservation Solutions
10
Manufactured under cGMP with supporting documentation and validation of processes
Animal Studies underway to ensure the absence of local and systemic toxicity
Evaluated with various cell types: Optimized for cryopreservation of MSCs as well as multicellular tissues
Release testing validations to be completed shortly, stability program to begin by end of 2019
eCTD DMF preparation underway, to be submitted by end of 2019
DoD SBIR Phase I/II and ARMI Grants awarded to support progress
CryoNovo A19 DMSO-Free Cryopreservation Medium
11CONFIDENTIAL NOT FOR FURTHER DISTRIBUTION
PROTEINS AND MEDIA SUPPLEMENTS
12
Manufactured under cGMP conditions in a licensed facility, DMF available (HSA)
Donors are traceable to the US; plasma units collected in FDA-registered facilities
Formulated with WFI (water for injection)
Do not contain additives/preservatives
High purity, low endotoxin
Donor plasma units viral tested as per 21 CFR 610.40
Custom packaging available such as vials, bags, syringes
Custom testing and gamma irradiation available upon request
Human Derived ProductsHSA, AB Serum, Fibronectin, Vitronectin, and Beyond
13CONFIDENTIAL NOT FOR FURTHER DISTRIBUTION
CONTRACT DEVELOPMENT AND MANUFACTURING SERVICES
14
Contract Protein Development and ManufacturingBoth microbial and mammalian cell derived recombinant proteins, including pegylation
Protein production from laboratory to commercial scale in 200L single-use bioreactors
Several high-throughput tools for development, processing, and analysis of purified recombinant proteins
Purified proteins can be delivered in either a liquid solution or as a shelf-stable lyophilized powder
All final products are processed in line with cGMP requirements to guarantee purity, quality, and consistency
15
CUSTOM MEDIA DEVELOPMENT, FORMULATION, AND TESTING
Component sourcing – including supplier qualification
Raw material testing (i.e. endotoxin) and screening
Comprehensive testing of final formulation
LARGE SCALE CONTRACT MEDIA MANUFACTURING (POWDER OR LIQUID)
30 – 500L production runs
cGMP manufacturing
Comprehensive testing services
Development and engineering runs
Aseptic fill in customized aliquots and packaging
Custom Media Development and Manufacturing
16
Plasmid DNA ManufacturingSequence and synthesize genes
Clone genes into plasmid vectors
Generate master and working cell banks
Plasmid DNA produced under cGMPs
Large scale production capacity (g) in single-use systems
Documentation and support for regulatory filings
17
Bioengineered Scaffold Development & Fabrication
TECHNIQUES· Emulsion Electrospinning· Co-axial Electrospinning· Post-Electrospinning Surface Modification· Sacrificial Fiber Electrospinning
MANUFACTURING CAPABILITIES· Lyophilization· Cryomilling· Surface modifications including Plasma Treatment· Immobilization of Biologicals
ANALYTICAL CAPABILITIES· Scanning Electron Microscopy (SEM) · Atomic Force Microscopy (AFM) · UV-Vis Spectrophotometry/ELISA· X-ray Photoelectron Spectroscopy (XPS) · Fluorescence Microscopy
Aligned Random Axially Aligned Tubular Grided
18
Class ISO 7/5 cleanrooms for contract manufacturing
PICS certification
ICH guidelines
Regulatory submissions
Full qualification, validation, and documentation
Release and stability testing
Commercial Contract Manufacturing
19
Aseptic Fill & Finish1. Identify critical components, perform a risk assessment, and find primary and secondary sources for critical components
2. Qualify and source raw materials from client’s approved suppliers/Akron approved suppliers
3. Transfer technology of any prior work completed on formulation or manufacturing processes
4. Complete aseptic media fill, development runs, and engineering/validation run to validate your sterile-fill claim
5. Set manufacturing process/specifications and final product specifications based on consistent and repeatable data
6. Formulate & fill in custom, single-use, and closed packaging
7. Set-up accelerated or concurrent stability studies to validate sterility claims in new packaging
8. Provide documentation and support for regulatory filings
20
Phone: +1.561.750.6120 Website: www.akronbiotech.com Email: [email protected] Sales Department: [email protected] Technical Support: [email protected] Customer Service: [email protected]